CPRX - Company ID 0001369568
The table below shows CATALYST PHARMACEUTICALS, INC.'s balance sheet line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $709.17M | $517.55M | $137.64M | $298.39M | $171.44M | $130.24M |
| Short-term investments | - | - | $0.00 | $0.00 | $19.82M | $10.04M |
| Receivables | $126.48M | $65.48M | $53.51M | $10.44M | $6.62M | $5.99M |
| Inventory | $37.17M | $19.54M | $15.64M | $6.80M | $7.87M | $4.65M |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Total current assets |
| $894.03M |
| $623.61M |
| $219.33M |
| $320.80M |
| $210.11M |
| $159.24M |
| Property, plant & equipment | $1.04M | $1.35M | $1.20M | $847.00K | $959.00K | $129.80K |
| Goodwill | - | - | - | - | - | - |
| Total assets | $1.10B | $851.41M | $470.11M | $375.63M | $237.79M | $192.35M |
| Accounts payable | $11.20M | $16.59M | $14.79M | $3.98M | $2.77M | $4.26M |
| Total current liabilities | $147.15M | $120.68M | $76.06M | $57.59M | $27.06M | $22.76M |
| Long-term debt | - | - | - | - | - | - |
| Total liabilities | $149.71M | $123.78M | $82.23M | $75.21M | $30.96M | $22.76M |
| Retained earnings | $474.19M | $285.16M | $121.27M | $49.86M | -$26.31M | -$53.71M |
| Total equity | $954.27M | $727.63M | $387.88M | $300.42M | $206.83M | $169.60M |